(R)-camphor affects expression ISO RGD:11336 6480464 Camphor analog affects the expression of SPARC mRNA CTD PMID:24704097 1,1-dichloroethene increases expression ISO RGD:11336 6480464 vinylidene chloride results in increased expression of SPARC mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:11336 6480464 1, 2-Dimethylhydrazine results in increased expression of SPARC mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:11336 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SPARC mRNA] CTD PMID:22206623 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of SPARC mRNA CTD PMID:21058326 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SPARC mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:11336 6480464 Ethinyl Estradiol results in increased expression of SPARC mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:11336 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPARC mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SPARC mRNA CTD PMID:17557909 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SPARC mRNA CTD PMID:16079270 17beta-estradiol multiple interactions ISO RGD:11336 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SPARC mRNA CTD PMID:19693291 17beta-estradiol multiple interactions ISO RGD:731035 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SPARC mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:11336 6480464 Estradiol results in decreased expression of SPARC mRNA CTD PMID:19693291 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11336 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPARC mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SPARC mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11336 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11336 6480464 Tetrachlorodibenzodioxin affects the expression of SPARC mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731035 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:11752688 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:11336 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] more ... CTD PMID:17994277 , PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:11336 6480464 Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA CTD PMID:17994277 , PMID:18200517 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of SPARC mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SPARC mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:11336 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SPARC mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:11336 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SPARC mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases methylation ISO RGD:731035 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SPARC gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO RGD:11336 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SPARC exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:11336 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SPARC mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:11336 6480464 Fenretinide results in decreased expression of SPARC mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:731035 6480464 Decitabine results in increased expression of SPARC mRNA, Decitabine results in increased expression of SPARC protein CTD PMID:17397030 , PMID:19177197 5-aza-2'-deoxycytidine multiple interactions ISO RGD:731035 6480464 [Decitabine affects the methylation of SPARC promoter] which affects the expression of SPARC mRNA more ... CTD PMID:18458674 , PMID:19177197 5-fluorouracil multiple interactions ISO RGD:731035 6480464 [decitabine affects the methylation of SPARC promoter] which affects the susceptibility to Fluorouracil CTD PMID:18458674 5-fluorouracil affects expression ISO RGD:11336 6480464 Fluorouracil affects the expression of SPARC mRNA CTD PMID:24704097 5-fluorouracil increases response to substance ISO RGD:731035 6480464 SPARC protein results in increased susceptibility to Fluorouracil CTD PMID:15902309 acetylsalicylic acid multiple interactions ISO RGD:731035 6480464 Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of SPARC protein] CTD PMID:17303692 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SPARC mRNA CTD PMID:28959563 aldehydo-D-glucose multiple interactions ISO RGD:731035 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 aldehydo-D-glucose decreases expression ISO RGD:731035 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of SPARC mRNA CTD PMID:16079270 all-trans-retinoic acid multiple interactions ISO RGD:11336 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SPARC mRNA more ... CTD PMID:17994277 , PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:731035 6480464 Tretinoin results in decreased expression of SPARC mRNA CTD PMID:33167477 all-trans-retinoic acid affects expression ISO RGD:11336 6480464 Tretinoin affects the expression of SPARC mRNA CTD PMID:24704097 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SPARC mRNA CTD PMID:24977338 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SPARC mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SPARC mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:731035 6480464 Antirheumatic Agents results in increased expression of SPARC mRNA CTD PMID:24449571 arachidonic acid decreases expression ISO RGD:731035 6480464 Arachidonic Acid results in decreased expression of SPARC mRNA CTD PMID:16704987 arsane affects methylation ISO RGD:731035 6480464 Arsenic affects the methylation of SPARC gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:731035 6480464 Arsenic affects the methylation of SPARC gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:731035 6480464 arsenite results in decreased expression of SPARC mRNA, arsenite results in decreased expression of SPARC protein CTD PMID:23974009 , PMID:26783756 arsenite(3-) increases methylation ISO RGD:731035 6480464 arsenite results in increased methylation of SPARC promoter CTD PMID:23974009 avobenzone increases expression ISO RGD:731035 6480464 avobenzone results in increased expression of SPARC mRNA CTD PMID:31016361 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 benzene decreases expression ISO RGD:731035 6480464 Benzene results in decreased expression of SPARC mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:11336 6480464 Benzo(a)pyrene results in increased expression of SPARC mRNA CTD PMID:22610609 , PMID:32417428 benzo[a]pyrene increases methylation ISO RGD:731035 6480464 Benzo(a)pyrene results in increased methylation of SPARC promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:11336 6480464 benzo(b)fluoranthene results in increased expression of SPARC mRNA CTD PMID:26377693 berberine increases expression ISO RGD:731035 6480464 Berberine results in increased expression of SPARC mRNA CTD PMID:26478571 bexarotene increases expression ISO RGD:731035 6480464 bexarotene results in increased expression of SPARC mRNA CTD PMID:17178900 bis(2-chloroethyl) sulfide increases expression ISO RGD:731035 6480464 Mustard Gas results in increased expression of SPARC mRNA CTD PMID:33491125 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SPARC mRNA, bisphenol A affects the expression of SPARC protein CTD PMID:20219716 , PMID:25181051 bisphenol A decreases methylation ISO RGD:731035 6480464 bisphenol A results in decreased methylation of SPARC gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:731035 6480464 bisphenol A results in increased expression of SPARC mRNA, bisphenol A results in increased expression of SPARC protein CTD PMID:31715268 , PMID:33376534 bisphenol A increases expression ISO RGD:11336 6480464 bisphenol A results in increased expression of SPARC mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:731035 6480464 bisphenol A results in decreased expression of SPARC mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:731035 6480464 bisphenol A affects the expression of SPARC mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SPARC mRNA, bisphenol A results in decreased expression of SPARC protein CTD PMID:20219716 more ... bisphenol F increases expression ISO RGD:11336 6480464 bisphenol F results in increased expression of SPARC mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:11336 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SPARC mRNA CTD PMID:30951980 bleomycin A2 increases response to substance ISO RGD:11336 6480464 SPARC protein results in increased susceptibility to Bleomycin CTD PMID:19446018 boric acid affects expression ISO RGD:11336 6480464 boric acid affects the expression of SPARC mRNA CTD PMID:24704097 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of SPARC mRNA CTD PMID:24136188 cadmium atom decreases expression ISO RGD:731035 6480464 Cadmium results in decreased expression of SPARC mRNA, Cadmium results in decreased expression of SPARC protein CTD PMID:20570719 more ... cadmium atom multiple interactions ISO RGD:731035 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPARC mRNA CTD PMID:29741670 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of SPARC mRNA CTD PMID:9232954 cadmium dichloride decreases expression ISO RGD:731035 6480464 Cadmium Chloride results in decreased expression of SPARC mRNA, Cadmium Chloride results in decreased expression of SPARC protein CTD PMID:20837119 cadmium dichloride multiple interactions ISO RGD:731035 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPARC mRNA CTD PMID:29741670 calciol multiple interactions ISO RGD:731035 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of SPARC protein CTD PMID:19092814 camphor affects expression ISO RGD:11336 6480464 Camphor analog affects the expression of SPARC mRNA CTD PMID:24704097 carbamazepine affects expression ISO RGD:731035 6480464 Carbamazepine affects the expression of SPARC mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:11336 6480464 Nanotubes, Carbon analog results in decreased expression of SPARC mRNA CTD PMID:25620056 carmustine affects response to substance ISO RGD:731035 6480464 SPARC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 casticin increases expression ISO RGD:11336 6480464 casticin results in increased expression of SPARC mRNA CTD PMID:28444820 casticin decreases expression ISO RGD:731035 6480464 casticin results in decreased expression of SPARC mRNA CTD PMID:27862857 CGP 52608 multiple interactions ISO RGD:731035 6480464 CGP 52608 promotes the reaction [RORA protein binds to SPARC gene] CTD PMID:28238834 chlorpyrifos decreases expression ISO RGD:11336 6480464 Chlorpyrifos results in decreased expression of SPARC mRNA CTD PMID:20350560 choline multiple interactions ISO RGD:11336 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:731035 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SPARC mRNA, [Cisplatin co-treated with Paclitaxel] results in decreased expression of SPARC mRNA CTD PMID:20705681 , PMID:27392435 cisplatin decreases expression ISO RGD:731035 6480464 Cisplatin results in decreased expression of SPARC mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:11336 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA CTD PMID:15467011 copper atom decreases expression EXP 6480464 Copper results in decreased expression of SPARC mRNA CTD PMID:30556269 copper atom increases expression ISO RGD:11336 6480464 Copper results in increased expression of SPARC mRNA CTD PMID:16629173 copper atom decreases secretion ISO RGD:11336 6480464 Copper results in decreased secretion of SPARC protein CTD PMID:19635393 copper(0) multiple interactions ISO RGD:11336 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA CTD PMID:15467011 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SPARC mRNA CTD PMID:30556269 copper(0) increases expression ISO RGD:11336 6480464 Copper results in increased expression of SPARC mRNA CTD PMID:16629173 copper(0) decreases secretion ISO RGD:11336 6480464 Copper results in decreased secretion of SPARC protein CTD PMID:19635393 crocidolite asbestos multiple interactions ISO RGD:11336 6480464 Asbestos more ... CTD PMID:19446018 crocidolite asbestos decreases expression ISO RGD:11336 6480464 Asbestos, Crocidolite results in decreased expression of SPARC mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO RGD:731035 6480464 Asbestos, Crocidolite results in decreased expression of SPARC mRNA CTD PMID:28056339 crocidolite asbestos increases response to substance ISO RGD:11336 6480464 SPARC protein results in increased susceptibility to Asbestos, Crocidolite CTD PMID:19446018 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SPARC mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:11336 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] CTD PMID:18200517 cyclophosphamide decreases expression ISO RGD:11336 6480464 Cyclophosphamide results in decreased expression of SPARC mRNA CTD PMID:15331540 cyclophosphamide increases expression ISO RGD:731035 6480464 Cyclophosphamide results in increased expression of SPARC mRNA CTD PMID:17403535 cyclosporin A decreases expression ISO RGD:731035 6480464 Cyclosporine results in decreased expression of SPARC mRNA CTD PMID:20106945 , PMID:25562108 cytarabine decreases expression ISO RGD:731035 6480464 Cytarabine results in decreased expression of SPARC mRNA CTD PMID:21198554 D-glucose decreases expression ISO RGD:731035 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 D-glucose multiple interactions ISO RGD:731035 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 DDT increases expression ISO RGD:731035 6480464 DDT results in increased expression of SPARC mRNA CTD PMID:25014179 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of SPARC mRNA CTD PMID:9232954 dextran sulfate multiple interactions ISO RGD:11336 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPARC mRNA CTD PMID:29950665 dioxygen increases expression ISO RGD:11336 6480464 Oxygen deficiency results in increased expression of SPARC mRNA CTD PMID:28174749 dioxygen multiple interactions ISO RGD:11336 6480464 GPR68 protein affects the reaction [Oxygen deficiency results in increased expression of SPARC mRNA] CTD PMID:28174749 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SPARC mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of SPARC mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:731035 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPARC mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:731035 6480464 Doxorubicin results in increased expression of SPARC mRNA CTD PMID:15870702 doxorubicin decreases expression ISO RGD:731035 6480464 Doxorubicin results in decreased expression of SPARC mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:11336 6480464 Doxorubicin results in increased expression of SPARC mRNA CTD PMID:15033991 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SPARC mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:731035 6480464 Ethanol results in increased expression of SPARC mRNA CTD PMID:15963989 ethanol decreases expression ISO RGD:11336 6480464 Ethanol results in decreased expression of SPARC mRNA CTD PMID:34755883 ethanol increases expression ISO RGD:11336 6480464 Ethanol results in increased expression of SPARC mRNA CTD PMID:30319688 Ethoxyacetic acid affects expression ISO RGD:11336 6480464 ethoxyacetic acid affects the expression of SPARC mRNA CTD PMID:24704097 fenamidone increases expression ISO RGD:11336 6480464 fenamidone results in increased expression of SPARC mRNA CTD PMID:27029645 fenthion increases expression ISO RGD:11336 6480464 Fenthion results in increased expression of SPARC mRNA CTD PMID:34813904 fipronil increases expression EXP 6480464 fipronil results in increased expression of SPARC mRNA CTD PMID:34044035 folic acid multiple interactions ISO RGD:11336 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:11336 6480464 Folic Acid results in decreased expression of SPARC mRNA CTD PMID:25629700 folic acid increases expression ISO RGD:731035 6480464 Folic Acid results in increased expression of SPARC mRNA CTD PMID:28752528 formaldehyde decreases expression ISO RGD:731035 6480464 Formaldehyde results in decreased expression of SPARC mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:731035 6480464 fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of SPARC mRNA] CTD PMID:26362186 furan increases expression EXP 6480464 furan results in increased expression of SPARC mRNA CTD PMID:27387713 furosemide increases expression EXP 6480464 Furosemide results in increased expression of SPARC mRNA CTD PMID:16526316 gallocatechin increases expression EXP 6480464 gallocatechol results in increased expression of SPARC mRNA CTD PMID:21877759 gamma-aminobutyric acid affects expression EXP 6480464 gamma-Aminobutyric Acid affects the expression of SPARC mRNA CTD PMID:24098073 gamma-Oryzanol (TN) affects expression EXP 6480464 gamma-oryzanol affects the expression of SPARC mRNA CTD PMID:24098073 genistein increases expression EXP 6480464 Genistein results in increased expression of SPARC mRNA CTD PMID:21877759 glucose decreases expression ISO RGD:731035 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 glucose multiple interactions ISO RGD:731035 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 glycerol 2-phosphate multiple interactions ISO RGD:731035 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 hydrogen peroxide increases expression ISO RGD:731035 6480464 Hydrogen Peroxide results in increased expression of SPARC mRNA CTD PMID:34581912 indometacin multiple interactions ISO RGD:11336 6480464 Indomethacin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] CTD PMID:17994277 isoflavones affects expression ISO RGD:731035 6480464 Isoflavones affects the expression of SPARC mRNA CTD PMID:16365062 L-ascorbic acid multiple interactions ISO RGD:731035 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 L-ascorbic acid 2-phosphate decreases expression ISO RGD:731035 6480464 ascorbate-2-phosphate results in decreased expression of SPARC mRNA CTD PMID:17306970 L-methionine multiple interactions ISO RGD:11336 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:11336 6480464 Lipopolysaccharides results in increased expression of SPARC mRNA CTD PMID:27339419 losartan decreases expression EXP 6480464 Losartan results in decreased expression of SPARC mRNA CTD PMID:15100363 magnesium atom increases expression ISO RGD:731035 6480464 Magnesium results in increased expression of SPARC protein CTD PMID:10397942 methyl methanesulfonate decreases expression ISO RGD:731035 6480464 Methyl Methanesulfonate results in decreased expression of SPARC mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:731035 6480464 methylmercuric chloride results in decreased expression of SPARC mRNA CTD PMID:23179753 methylmercury(1+) increases expression EXP 6480464 methylmercury II results in increased expression of SPARC mRNA CTD PMID:17905399 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of SPARC mRNA CTD PMID:15954086 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SPARC mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:731035 6480464 Methylnitronitrosoguanidine results in decreased expression of SPARC mRNA CTD PMID:12634122 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SPARC mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO RGD:11336 6480464 Diethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SPARC mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SPARC mRNA CTD PMID:24136188 notoginsenoside R1 multiple interactions ISO RGD:731035 6480464 fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of SPARC mRNA] CTD PMID:26362186 notoginsenoside R1 increases expression ISO RGD:731035 6480464 notoginsenoside R1 results in increased expression of SPARC mRNA CTD PMID:26362186 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SPARC mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of SPARC mRNA CTD PMID:25729387 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of SPARC mRNA CTD PMID:27638505 paclitaxel multiple interactions ISO RGD:731035 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of SPARC mRNA CTD PMID:20705681 paclitaxel increases expression ISO RGD:731035 6480464 Paclitaxel results in increased expression of SPARC mRNA CTD PMID:19682730 palbociclib increases expression ISO RGD:731035 6480464 palbociclib results in increased expression of SPARC mRNA CTD PMID:28620137 paracetamol affects expression ISO RGD:11336 6480464 Acetaminophen affects the expression of SPARC mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SPARC mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:731035 6480464 Acetaminophen results in decreased expression of SPARC mRNA CTD PMID:29067470 perfluorononanoic acid decreases expression ISO RGD:731035 6480464 perfluoro-n-nonanoic acid results in decreased expression of SPARC mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO RGD:731035 6480464 perfluorooctane sulfonic acid affects the expression of SPARC mRNA CTD PMID:30738844 phenobarbital affects expression ISO RGD:731035 6480464 Phenobarbital affects the expression of SPARC mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:731035 6480464 Phenylmercuric Acetate results in increased expression of SPARC mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731035 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPARC mRNA CTD PMID:27188386 piroxicam decreases expression ISO RGD:731035 6480464 Piroxicam results in decreased expression of SPARC mRNA CTD PMID:21858171 poly(vinylpyrrolidone) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 potassium dichromate increases expression ISO RGD:11336 6480464 Potassium Dichromate results in increased expression of SPARC mRNA CTD PMID:23608068 progesterone multiple interactions ISO RGD:11336 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SPARC mRNA CTD PMID:19693291 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of SPARC mRNA CTD PMID:16079270 resveratrol decreases expression ISO RGD:731035 6480464 resveratrol results in decreased expression of SPARC mRNA, resveratrol results in decreased expression of SPARC protein CTD PMID:16084059 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of SPARC mRNA CTD PMID:19228061 rimonabant multiple interactions ISO RGD:11336 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SPARC mRNA] CTD PMID:19030233 rimonabant affects expression ISO RGD:11336 6480464 Rimonabant affects the expression of SPARC mRNA CTD PMID:19030233 rotenone affects expression EXP 6480464 Rotenone affects the expression of SPARC mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:731035 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPARC mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:731035 6480464 Asbestos, Serpentine results in decreased expression of SPARC mRNA CTD PMID:21148743 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SPARC mRNA CTD PMID:22431001 silver atom multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 silver(0) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 sodium arsenite multiple interactions ISO RGD:731035 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of SPARC promoter CTD PMID:18448484 sodium arsenite increases expression ISO RGD:731035 6480464 sodium arsenite results in increased expression of SPARC mRNA CTD PMID:20371982 sodium arsenite decreases expression ISO RGD:731035 6480464 sodium arsenite results in decreased expression of SPARC mRNA, sodium arsenite results in decreased expression of SPARC protein CTD PMID:20837119 sodium arsenite decreases expression ISO RGD:11336 6480464 sodium arsenite results in decreased expression of SPARC mRNA CTD PMID:18812580 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of SPARC mRNA CTD PMID:24300170 sodium fluoride multiple interactions EXP 6480464 DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of SPARC mRNA] CTD PMID:24300170 Soman increases expression EXP 6480464 Soman results in increased expression of SPARC mRNA CTD PMID:19281266 streptozocin increases expression ISO RGD:11336 6480464 Streptozocin results in increased expression of SPARC mRNA, Streptozocin results in increased expression of SPARC protein CTD PMID:12660331 sunitinib decreases expression ISO RGD:731035 6480464 Sunitinib results in decreased expression of SPARC mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:731035 6480464 SPARC mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide decreases expression ISO RGD:731035 6480464 tert-Butylhydroperoxide results in decreased expression of SPARC mRNA CTD PMID:15336504 tert-butyl hydroperoxide increases expression ISO RGD:731035 6480464 tert-Butylhydroperoxide results in increased expression of SPARC mRNA CTD PMID:15963989 testosterone increases expression ISO RGD:11336 6480464 Testosterone results in increased expression of SPARC mRNA CTD PMID:19693291 tetrachloromethane affects expression ISO RGD:11336 6480464 Carbon Tetrachloride affects the expression of SPARC mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11336 6480464 Carbon Tetrachloride results in increased expression of SPARC mRNA CTD PMID:27339419 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SPARC mRNA CTD PMID:16239168 , PMID:17056239 thioacetamide affects response to substance ISO RGD:11336 6480464 SPARC protein affects the susceptibility to Thioacetamide CTD PMID:23408952 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SPARC mRNA CTD PMID:28943392 thioacetamide multiple interactions ISO RGD:11336 6480464 SPARC protein affects the reaction [Thioacetamide results in increased expression of COL1A2 mRNA] more ... CTD PMID:23408952 thioacetamide increases expression ISO RGD:11336 6480464 Thioacetamide results in increased expression of SPARC mRNA CTD PMID:23408952 titanium dioxide decreases expression ISO RGD:11336 6480464 titanium dioxide results in decreased expression of SPARC mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:11336 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPARC mRNA CTD PMID:29950665 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SPARC mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SPARC mRNA CTD PMID:25729387 Trapidil multiple interactions EXP 6480464 Trapidil affects the reaction [PTH protein affects the expression of SPARC mRNA] CTD PMID:18635661 triacsin C decreases expression ISO RGD:731035 6480464 triacsin C results in decreased expression of SPARC mRNA CTD PMID:16704987 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SPARC mRNA CTD PMID:19448997 triclosan increases expression ISO RGD:731035 6480464 Triclosan results in increased expression of SPARC mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:11336 6480464 triptonide results in decreased expression of SPARC mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:11336 6480464 Valproic Acid affects the expression of SPARC mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:731035 6480464 Valproic Acid results in increased expression of SPARC mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:731035 6480464 Valproic Acid affects the expression of SPARC mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:731035 6480464 Valproic Acid results in decreased expression of SPARC mRNA CTD PMID:23179753 , PMID:29154799 vancomycin decreases expression ISO RGD:11336 6480464 Vancomycin results in decreased expression of SPARC mRNA CTD PMID:18930951